Please wait
0001728117EX-FILING FEESS-3ASRN/AN/Aiso4217:USD00017281172026-01-282026-01-28000172811712026-01-282026-01-28000172811722026-01-282026-01-28000172811732026-01-282026-01-28000172811742026-01-282026-01-28000172811752026-01-282026-01-28

Exhibit 107
Calculation of Filing Fee Tables

Form S-3
(Form Type)

Gossamer Bio, Inc.
(Exact Name of Registrant as Specified in its Charter)

Table 1: Newly Registered and Carry Forward Securities
1


Security Type
Security
Class
Title
Fee
Calculation
or Carry
Forward Rule
Amount
Registered
Proposed
Maximum
Offering Price
Per Unit
Maximum
Aggregate
Offering Price
Fee Rate
Amount of
Registration Fee
Carry
Forward
Form
Type
Carry
Forward
File
Number
Carry
Forward
Initial
effective
date
Filing Fee
Previously
Paid In
Connection
with
Unsold
Securities
to
be Carried
Forward
Newly Registered Securities
Fees to Be Paid



EquityCommon Stock, $0.0001 par value per share457(r)(1)(2)(2)$138.10 per $1,000,000(3)
EquityPreferred Stock, $0.0001 par value per share457(r)(1)(2)(2)$138.10 per $1,000,000(3)
DebtDebt Securities457(r)(1)(2)(2)$138.10 per $1,000,000(3)
OtherWarrants457(r)(1)(2)(2)$138.10 per $1,000,000(3)
OtherUnits457(r)(1)(2)(2)$138.10 per $1,000,000(3)
Fees Previously PaidN/AN/AN/AN/AN/AN/AN/A
Carry Forward Securities
Carry Forward SecuritiesN/AN/AN/AN/AN/AN/AN/A
Total Offering Amounts$$
Total Fees Previously PaidN/A
Total Fee OffsetsN/A
Net Fee Due$
(1)Omitted pursuant to Form S-3 General Instruction II.E. Includes rights to acquire common stock or preferred stock of the Gossamer Bio, Inc. (the “Registrant”) under any shareholder rights plan then in effect, if applicable under the terms of any such plan.
(2)An unspecified number of securities or aggregate principal amount, as applicable, is being registered as may from time to time be offered at unspecified prices and, in addition, an unspecified number of additional shares of Common Stock is being registered as may be issued from time to time upon conversion of any Debt Securities that are convertible into Common Stock or pursuant to any anti-dilution adjustments with respect to any such convertible Debt Securities.
(3)In accordance with Rules 456(b) and 457(r) under the Securities Act of 1933, as amended, the registrant is deferring payment of the entire registration fee.
2